James C. Katzaroff


James C. Katzaroff is highly regarded internationally for his proven expertise in corporate engineering as well as developing and implementing impactful senior-level corporate strategy. Mr. Katzaroff is passionate about fostering critical investment banking and private investor relationships as well as managing intricate stakeholder relationships. Associates and clients continue to trust Mr. Katzaroff with their most critical business needs because of his passion, commitment and proven ability to be a solution provider and create win-win outcomes to the most complex issues that challenge all growth companies.  He has significant experience in the healthcare and medical fields and is a graduate of the University of California, Santa Barbara.

William J. Farley

Board of Directors, Development Officer

BIll Farley, has over 35 years’ experience in the Business Development, Sales and leading efforts in drug discovery, development and partnering. Prior to joining Sorrento Therapeutics, Mr. Farley began his career at Johnson and Johnson and has also held a positions at Pfizer and has held leadership positions at HitGen Ltd , Vice President , WuXi Apptec, Inc. building and leading a global BD team, VP of BD at ChemDiv where he lead numerous efforts to create new therapeutic companies in CNS, Oncology and Anti infectives. Mr. Farley has served as a consultant to various executive management teams and advise several BODs on commercialization assets. Mr. Farley has spoken at numerous conferences and is published in variety of journals, received his Bachelor of Science degree in Chemistry from State University of New York , Oswego and graduate courses at Rutgers and UC Irvine

Steven F. Penderghast

Board of Directors, Commercial Officer

Mr. Steven F. Penderghast joined the Angiosoma team in 2021 and serves as its Commercial Officer, overseeing market channel development and execution of the companies neuromuscular therapeutic applications. His 30 year career has focused on the product management, market development and commercialization of medical devices, capital equipment and biologics. Steven’s experience spans roles from clinical and regulatory affairs, product development, market development, sales management, contracting and corporate account relationship management.

Most recently, Steven served as Corporate Vice President, Health Systems & National Accounts with Becton Dickinson Inc., and Corporate Vice President National Accounts for CR Bard Inc., implementing market channel strategy and overseeing corporate relationships at the largest IDNs and GPOs in the United States. Prior to this, Steven held strategic development roles in both start-up ventures and in large global healthcare corporations. He has marketed technologies in the areas of: Vascular and Oncology Drug Delivery, Tumor Ablation, Oncology Therapeutics, Cardiovascular Intervention, Imaging, Urology, General Surgery, and Diagnostics.

He is a graduate of Pepperdine University, California, in Business Administration with an undergraduate focus in Statistics.

Brooke Greenwald

Chief Marketing Officer

Brooke Greenwald founded Cornerstone Communications, LTD over two decades ago. As an award-winning public relations, marketing and communications professional, Ms. Greenwald has written for hundreds of publications, created content for many of today’s most recognizable companies and their brands, managed full marketing campaigns, created and implemented major public relations and communications campaigns, and worked for some of the largest news organizations in existence today. She has focused her career on healthcare, technology, security, and communications. Greenwald is a former journalist and has worked inside most of the major news networks. Ms. Greenwald holds a master’s degree in Public Relations from the University of Maryland at College Park.

Dr. Leonard Wisneski, MD

Chairman, Medical Advisory Board

Leonard A. Wisneski, MD, FACP is Clinical Professor of Medicine at George Washington University, Adjunct Faculty in the Department of Biochemistry and Molecular Biology at Georgetown University and also holds faculty positions in the Medicine and Nursing Departments at The University of Colorado. He has been in the clinical practice of endocrinology and for over 30 years and is a recognized leader globally in the field of integrative and whole person health.

Dr. Wisneski holds fellowship positions in The American College of Physicians and The American College of Nutrition. He was Chairman of the National Institute of Health (NIH) Advisory Board on Frontier Sciences at the University of Connecticut and Vice Chairman of the NIH Consensus Panel on Acupuncture. He has published over 30 scientific articles and a textbook, “Scientific Basis of Integrative Health, Third Edition.”

Dr. Wisneski is Chairman Emeritus of the Integrative Health Policy Consortium which promotes national legislation pertaining to integrative healthcare. His medical practice in endocrinology and integrative medicine, spanning three decades, embodies the true meaning of integrative healthcare – an optimal combination of conventional and complementary medicine practiced with a whole-person approach delivered with reverence and humanism. He is also a donor to the Strauss -Wisneski Indigenous and Integrative Medicine Collection housed within the Strauss Health Sciences Library at The University of Colorado.

Dr. Wisneski graduated from Thomas Jefferson Medical College and performed his postgraduate training in the field of Internal Medicine and Endocrinology in the George Washington University healthcare system, where he served as Chief Medical Resident in Internal Medicine.